CompletedNCT04884399
Phase I Study to Compare CMAB818 Injection and Lucentis® in Patients With Wet AMD
PHASE1 · 24 planned enrolment
- Countries listed
- 1
- Registry update
- March 28, 2024
immortal.lifeTrial registrations containing the exact intervention label Lucentis®.
No aliases or equivalent products have been inferred.
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →PHASE1 · 24 planned enrolment
PHASE1 · 30 planned enrolment